QL
RCUS icon

Quarry LP’s Arcus Biosciences RCUS Stock Holding History

Quarry LP’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,750
Closed -$51.9K – 2044
2024
Q1 		$51.9K Buy
2,750
+1,750
+175% +$30.3K 0.01% 445
2023
Q4 		$19.1K Sell
1,000
-3,972
-80% -$63.5K ﹤0.01% 780
2023
Q3 		$89.2K Buy
+4,972
New +$99.9K 0.02% 220

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quarry LP's RCUS Position: Q2 2024 in Review

Quarry LP sold out of Arcus Biosciences (RCUS) in Q2 2024, closing a stake of 2,750 shares — an estimated $51.9K sold.

Quarry LP first reported a position in RCUS in Q3 2023 and held it in 3 quarters. The position peaked at $89.2K in Q3 2023. 193 funds tracked by Wall St. Rank hold RCUS as of Q2 2024.

  • Quarry LP reported no remaining Arcus Biosciences position as of Q2 2024 after selling out during the quarter.
  • Quarry LP sold 2,750 Arcus Biosciences shares in Q2 2024, an estimated $51.9K.
  • Quarry LP first reported a position in Arcus Biosciences in Q3 2023 and held it in 3 quarters.
  • Quarry LP's Arcus Biosciences position peaked at $89.2K in Q3 2023.
  • 193 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2024.

Based on Quarry LP's 13F filing for Q2 2024, filed 14 Aug 2024.